Balmes Transplantation
PrivateCompany Overview
Balmes Transplantation operates in Healthcare & Life Sciences and is based in Marseille. It was founded in 2015.
Balmes Transplantation was a pharmaceutical company that developed drug candidates for reducing ischemia-reperfusion injuries in organ transplantation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Balmes Transplantation Comparables
Compare Balmes Transplantation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| cellvie | 82% | |
| Morningside | 70% | |
| Ischemix, Inc. | 69% |
For institutional investors. Book with your work email.
Balmes Transplantation Funding Rounds
Historical fundraising activity
Balmes Transplantation Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Balmes Transplantation's valuation, stock price, and market status.
Is Balmes Transplantation a public or private company?
Balmes Transplantation is a private company.
What is the current stock price of Balmes Transplantation?
Balmes Transplantation is a private company, so its shares have no public market price. Caplight tracks Balmes Transplantation's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Balmes Transplantation worth (valuation)?
Valuation information for Balmes Transplantation is not publicly available.
Can I buy Balmes Transplantation stock?
Balmes Transplantation shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Balmes Transplantation's last funding round?
Funding round information for Balmes Transplantation is not publicly available.
Who are the main investors in Balmes Transplantation?
Investor information for Balmes Transplantation is not publicly disclosed.
Will Balmes Transplantation IPO soon?
No public IPO plans have been announced for Balmes Transplantation.
How can I track Balmes Transplantation secondary market activity?
Caplight tracks bids, offers, and trades in Balmes Transplantation's shares on secondary markets.